Skip to main content

and
  1. Article

    Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry

    In the version of this Letter originally published, the authors reported on the use of 2,5-dimethylpyrrolyl benzoic acid to block Ephrin receptors. In 2011, it was reported that newly synthesized 2,5-dimethylp...

    Hua Zhang, Yan Li, Hong-Bo Wang, Ao Zhang, Mei-Ling Chen in Nature Microbiology (2018)

  2. No Access

    Article

    Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry

    Epstein–Barr virus (EBV) is causally associated with nasopharyngeal carcinoma, 10% of gastric carcinoma and various B cell lymphomas 1 . EBV infects both B cells and epithelial c...

    Hua Zhang, Yan Li, Hong-Bo Wang, Ao Zhang, Mei-Ling Chen in Nature Microbiology (2018)

  3. No Access

    Article

    Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing

    The latent expression pattern of Epstein-Barr Virus (EBV) genes in nasopharyngeal carcinoma (NPC) has been extensively investigated, and the expression of several lytic genes in NPC has been reported. However,...

    Lijuan Hu, Zhirui Lin, Yanheng Wu, Juqin Dong, Bo Zhao in Frontiers of Medicine (2016)

  4. Article

    Open Access

    Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells

    Epstein–Barr virus (EBV) is implicated as an aetiological factor in B lymphomas and nasopharyngeal carcinoma. The mechanisms of cell-free EBV infection of nasopharyngeal epithelial cells remain elusive. EBV gl...

    Hong-Bo Wang, Hua Zhang, **g-** Zhang, Yan Li, Bo Zhao in Nature Communications (2015)

  5. Article

    Open Access

    Epstein–Barr virus latent genes

    Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many human disorders. The persistence of these viral genomes in all malignant cells, yet with the expression of limited latent genes,...

    Myung-Soo Kang, Elliott Kieff in Experimental & Molecular Medicine (2015)

  6. No Access

    Article

    Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins

    Combining analysis of host proteome and transcriptome perturbations induced by tumour virus proteins with ongoing genome-wide studies of cancer facilitates the prioritization of cancer genes.

    Orit Rozenblatt-Rosen, Rahul C. Deo, Megha Padi, Guillaume Adelmant in Nature (2012)

  7. No Access

    Chapter

    Epstein–Barr Virus Latent Infection Nuclear Proteins: Genome Maintenance and Regulation of Lymphocyte Cell Growth and Survival

    Eric Johannsen, Michael Calderwood, Myung-Soo Kang, Bo Zhao in DNA Tumor Viruses (2009)

  8. No Access

    Chapter

    LMP1 TRAFficking Activates Growth and Survival pathways

    Epstein-Barr Virus (EBV) Latent Infection Membrane Protein 1 (LMP1) is expressed in all the EBV related malignancies. LMP1 expression is critical for transformation of human B-cells by EBV. LMP1 expression in ...

    Vishal Soni, Ellen Cahir-McFarland in TNF Receptor Associated Factors (TRAFs) (2007)

  9. No Access

    Chapter and Conference Paper

    NF-κB Inhibition in EBV-Transformed Lymphoblastoid Cell Lines

    Epstein-Barr virus (EBV) transforms B-l/mphocytes into lymphoblastoid cell lines usur** multiple signaling pathways including NF-κB activation. To determine whether NF-κB activity is essential in the growth ...

    Ellen Cahir-McFarland, Elliott Kieff in Immunosurveillance, Immunodeficiencies and… (2002)

  10. No Access

    Article

    Why commonplace encounters turn to fatal attraction

    Michel Sadelain, Elliott Kieff in Nature Genetics (1998)

  11. No Access

    Article

    Molecular basis for Epstein-Barr virus induced pathogenesis and disease

    In summary, information obtained from single gene transfer into EBV-negative cell lines is consistent with molecular genetic analysis of in vitro transformation by the whole virus in emphasizing the role for E...

    Clare Sample, Elliott Kieff in Springer Seminars in Immunopathology (1991)

  12. No Access

    Chapter

    Epstein-Barr Virus Recombinants: Use of Positive Selection Markers to Rescue Mutants in EBV Negative B Lymphoma Cells

    Epstein-Barr virus (EBV) genetic analyses have been restricted because the in vitro host range is limited to primate B lymphocytes which are largely non-permissive for EBV replication (1). Further, recovery of...

    Andrew Marchini, Fred Wang, Elliott Kieff in Epstein-Barr Virus and Human Disease · 1990 (1991)

  13. No Access

    Chapter

    Cell Growth Transformation by Epstein Barr Virus

    Epstein-Barr Virus (EBV) was discovered 25 years ago during a search for an etiologic agent in human Burkitt lymphoma (BL), a remarkably unusual, geographically restricted, tumor. In vitro infection of primary...

    Elliott Kieff, Fred Wang, Mark Birkenbach in Neoplastic Transformation in Human Cell Cu… (1991)

  14. No Access

    Chapter

    Epstein-Barr Virus Transformation of B Lymphocytes: Molecular Pathogenesis

    Primary Epstein-Barr Virus (EBV) infection begins in the oropharynx where the virus establishes persistent infection of epithelial cells through continued cycles of infection, virus replication, cell death, vi...

    David Liebowitz, Elliott Kieff in Epstein-Barr Virus and Human Disease • 1988 (1989)

  15. No Access

    Chapter

    Persistence and Expression of the Epstein-Barr Virus Genome in Latent Infection and Growth Transformation of Lymphocytes

    Epstein-Barr Virus (EBV) is believed to be an important etiologic agent of nasopharyngeal cancers (NPC) especially of the anaplastic type since (i) NPC cells invariably harbor EBV (Wolf et al., 1975; Huang et ...

    Elliott Kieff, Kevin Hennessy in Epstein-Barr Virus and Associated Diseases (1985)

  16. No Access

    Article

    Libri novi

    Wm. Bridge Cooke, Abe Widra, John W. Rippon in Mycopathologia et mycologia applicata (1974)